Month: May 2026
Executive Order Accelerates Reclassification for Medical Marijuana, Keeps Reclassification Timeline Started Under Biden Administration
On April 23, 2026, the Department of Justice (DOJ) and the Drug Enforcement Administration (DEA) issued an executive order (the…
TSA clarifies “no changes” in medical cannabis policy for airports (Newsletter: May 21, 2026)
Poll: Marijuana cooler than crypto; VA hemp biz say veto an “opportunity”; LA medical marijuana in hospitals vote; Study: CBG…
State regulators freeze testing at major Minnesota marijuana lab
Legend Technical Services, one of only a few fully operational labs for cannabis and hemp products in Minnesota, has been…
Jushi pauses $50M Virginia expansion after Spanberger vetoes cannabis bill
A publicly traded medical marijuana company had been gearing up for a big Virginia expansion. That changed Tuesday when Gov….
Reaction after Virginia governor vetoes cannabis market bills
Virginia Gov. Abigail Spanberger vetoed a bill to create a legal cannabis market, drawing criticism from Sen. Lashrecse Aird.
Cannabis bill that would allow recreational sales in Paramus advances
Paramus mayor opposes NJ proposal that would OK recreational marijuana sales in town, bypassing local zoning laws …
Leave a Comment on O’Brien officially out as Healey appoints new Cannabis Control Commission members
O’Brien officially out as Healey appoints new Cannabis Control Commission members
Governor Maura Healey on Tuesday appointed three new leaders to run the Cannabis Control Commission, which regulates the marijuana industry….
Cannabis Stocks Draw Attention As Rescheduling Debate Gains Momentum
Explore how cannabis rescheduling is reshaping marijuana stocks, operational growth, and market positioning across leading North American cannabis companies.
Healey taps executive branch veteran to lead Cannabis Control Commission
Massachusetts Gov. Maura Healey appointed Christopher Harding, Xiomara DeLobato and Anthony Wilson to lead the Cannabis Control Commission through a…
Auxly Cannabis is still undervalued, this analyst says
Haywood analyst Neal Gilmer maintained a “Buy” rating and $0.25 target on Auxly Cannabis Group (Auxly Cannabis Group Stock Quote,…
Recent Comments